Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 9, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 13, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001213900-26-077633
Filed / recorded
Jul 13, 2026, 9:06 PM UTC
Added to OQRO
Oct 8, 2026, 9:25 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
REGENTIS BIOMATERIALS LTD.
Issuer CIK
1912966
Ticker
RGNT
Reporting person
Jeff Dykan
Relationship
Director
Security
Employee Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Jul 9, 2026
Transaction code
A
Shares / units
24,826
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
24,826
Ownership form
Direct
Amendment
No
Footnotes from the filing
This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026.
This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029.
To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee.